Positive News SentimentPositive NewsNASDAQ:ATRI Atrion (ATRI) Stock Forecast, Price & News $561.80 +3.80 (+0.68%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$561.80▼$561.8050-Day Range$500.00▼$659.0052-Week Range$500.00▼$705.74Volume1,869 shsAverage Volume3,214 shsMarket Capitalization$988.77 millionP/E Ratio33.40Dividend Yield1.53%Price TargetN/A ProfileProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Atrion MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy2.55% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainabilityN/ANews Sentiment1.55Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.63 out of 5 starsMedical Sector115th out of 987 stocksSurgical & Medical Instruments Industry10th out of 95 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Atrion. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.55% of the float of Atrion has been sold short.Short Interest Ratio / Days to CoverAtrion has a short interest ratio ("days to cover") of 9.Change versus previous monthShort interest in Atrion has recently decreased by 3.66%, indicating that investor sentiment is improving. Previous Next 3.3 Dividend Strength Dividend YieldAtrion pays a meaningful dividend of 1.54%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthAtrion has been increasing its dividend for 19 years.Dividend CoverageThe dividend payout ratio of Atrion is 51.13%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ATRI. Previous Next 3.6 News and Social Media Coverage News SentimentAtrion has a news sentiment score of 1.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Atrion this week, compared to 1 article on an average week.MarketBeat Follows2 people have added Atrion to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Atrion insiders have not sold or bought any company stock.Percentage Held by Insiders22.70% of the stock of Atrion is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.90% of the stock of Atrion is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Atrion is 33.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.01.Price to Earnings Ratio vs. SectorThe P/E ratio of Atrion is 33.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 91.88.Price to Book Value per Share RatioAtrion has a P/B Ratio of 4.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Atrion (NASDAQ:ATRI) StockAtrion Corp. engages in the manufacture and development of products for medical applications. It offers products for cardiovascular, fluid delivery, and ophthalmic. It also offers contract manufacturing and kitting services, and marine & aviation inflation components. The company was founded in 1944 and is headquartered in Allen, TX.Read More Receive ATRI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter. Email Address ATRI Stock News HeadlinesJune 10, 2023 | americanbankingnews.comAtrion (NASDAQ:ATRI) Shares Gap Up to $548.99June 5, 2023 | finance.yahoo.comStudy unable to firmly connect legal pot and truck safetyJune 10, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>May 29, 2023 | proactiveinvestors.comPlurilock Security reports surge in 1Q revenue following acquisitions, organic growthMay 26, 2023 | finance.yahoo.comATRI - Atrion CorporationMay 19, 2023 | msn.comAtrion: Trading Below Value, Volatility Presents MispricingsMay 18, 2023 | americanbankingnews.comAtrion (NASDAQ:ATRI) Now Covered by Analysts at StockNews.comMay 11, 2023 | americanbankingnews.comAtrion (NASDAQ:ATRI) Sees Large Volume IncreaseJune 10, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>May 11, 2023 | marketwatch.comBeating Heart Surgery System Market Size 2023-2031 Industrial Overview by Absolute Reports | with [93 Pages]May 10, 2023 | finance.yahoo.comPlurilock Receives 2023 BlackBerry NALA Partner of the Year Award at the BlackBerry Partner Cybersecurity Sales Kick-Off Award CeremonyMay 9, 2023 | finance.yahoo.comAtrion (NASDAQ:ATRI) Will Want To Turn Around Its Return TrendsMay 9, 2023 | finanznachrichten.deAtrion Corporation: Atrion Reports First Quarter 2023 ResultsMay 9, 2023 | marketwatch.com10-Q: ATRION CORPMay 8, 2023 | finance.yahoo.comAtrion Reports First Quarter 2023 ResultsMay 3, 2023 | marketwatch.comCardiovascular Surgery Devices Market Growth Analysis 2023 to 2030 | Abbott Laboratories, Boston Scientific Corporation, Cook Medical, C.R.BardApril 29, 2023 | marketwatch.comBalloon Catheter Pumps Market By Manufacturers, Regions,and Forecast 2030April 28, 2023 | americanbankingnews.comHead to Head Analysis: CVR Medical (OTCMKTS:CRRVF) vs. Atrion (NASDAQ:ATRI)April 27, 2023 | marketwatch.comOphthalmic Diagnostic Devices Market Demand by 2031April 26, 2023 | marketwatch.comContact Lenses Accessories Market Future Trends Demand 2023, and Forecast to 2030 | Johnson and Johnson Vision Care, NovartisApril 25, 2023 | marketwatch.comCardiac Surgical Devices Market Forecasted from 2023-2031April 24, 2023 | uk.finance.yahoo.comAtrion Corporation (ATRI) stock historical prices & data – Yahoo FinanceApril 22, 2023 | americanbankingnews.comAtrion Co. (NASDAQ:ATRI) Sees Significant Decrease in Short InterestApril 19, 2023 | americanbankingnews.comAtrion (NASDAQ:ATRI) Shares Gap Down to $644.78March 31, 2023 | finance.yahoo.comDo Its Financials Have Any Role To Play In Driving Atrion Corporation's (NASDAQ:ATRI) Stock Up Recently?March 27, 2023 | marketwatch.comGlobal Diagnostic Ophthalmic Devices Market Size 2023 to 2026 Size and Share Survey ReportMarch 24, 2023 | marketwatch.comA Closer Look at the Contact Lenses Accessories Market (2023 to 2030)-Opportunities and ChallengesSee More Headlines ATRI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ATRI Company Calendar Last Earnings11/01/2019Ex-Dividend for 3/31 Dividend3/14/2023Dividend Payable3/31/2023Today6/10/2023Ex-Dividend for 6/30 Dividend6/14/2023Dividend Payable6/30/2023Next Earnings (Estimated)8/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:ATRI CUSIP04990410 CIK701288 Webwww.atrioncorp.com Phone(972) 390-9800Fax972-396-7581Employees667Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$16.82 Trailing P/E Ratio33.40 Forward P/E RatioN/A P/E GrowthN/ANet Income$35.01 million Net Margins17.01% Pretax Margin19.53% Return on Equity12.36% Return on Assets11.18% Debt Debt-to-Equity RatioN/A Current Ratio6.67 Quick Ratio2.30 Sales & Book Value Annual Sales$183.51 million Price / Sales5.39 Cash Flow$27.73 per share Price / Cash Flow20.26 Book Value$135.13 per share Price / Book4.16Miscellaneous Outstanding Shares1,760,000Free Float1,360,000Market Cap$988.77 million OptionableNot Optionable Beta0.48 Key ExecutivesDavid A. BattatPresident & Chief Executive OfficerCindy FergusonCFO, Secretary, Treasurer & Vice PresidentKey CompetitorsCerusNASDAQ:CERSOraSure TechnologiesNASDAQ:OSURAnika TherapeuticsNASDAQ:ANIKUtah Medical ProductsNASDAQ:UTMDSI-BONENASDAQ:SIBNView All CompetitorsInsiders & InstitutionsProShare Advisors LLCBought 131 shares on 5/26/2023Ownership: 0.854%Ameriprise Financial Inc.Bought 45 shares on 5/22/2023Ownership: 0.048%JPMorgan Chase & Co.Bought 383 shares on 5/18/2023Ownership: 0.118%New York State Common Retirement FundSold 200 shares on 5/18/2023Ownership: 0.051%Steward Partners Investment Advisory LLCBought 101 shares on 5/16/2023Ownership: 0.014%View All Insider TransactionsView All Institutional Transactions ATRI Stock - Frequently Asked Questions How have ATRI shares performed in 2023? Atrion's stock was trading at $559.45 at the beginning of 2023. Since then, ATRI shares have increased by 0.4% and is now trading at $561.80. View the best growth stocks for 2023 here. When is Atrion's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023. View our ATRI earnings forecast. How were Atrion's earnings last quarter? Atrion Co. (NASDAQ:ATRI) issued its earnings results on Friday, November, 1st. The medical instruments supplier reported $5.15 earnings per share for the quarter. The medical instruments supplier had revenue of $38.88 million for the quarter. Atrion had a net margin of 17.01% and a trailing twelve-month return on equity of 12.36%. How often does Atrion pay dividends? What is the dividend yield for Atrion? Atrion announced a quarterly dividend on Tuesday, May 23rd. Investors of record on Thursday, June 15th will be given a dividend of $2.15 per share on Friday, June 30th. This represents a $8.60 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date is Wednesday, June 14th. Read our dividend analysis for ATRI. What ETFs hold Atrion's stock? ETFs with the largest weight of Atrion (NASDAQ:ATRI) stock in their portfolio include Small Cap US Equity Select ETF (RNSC), ProShares Russell 2000 Dividend Growers ETF (SMDV), SPDR S&P Health Care Equipment ETF (XHE), Royce Quant Small-Cap Quality Value ETF (SQLV), Timothy Plan US Small Cap Core ETF (TPSC), iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), Vanguard U.S. Quality Factor ETF (VFQY) and Hartford Multifactor Small Cap ETF (ROSC). Is Atrion a good dividend stock? Atrion (NASDAQ:ATRI) pays an annual dividend of $8.60 per share and currently has a dividend yield of 1.54%. The company has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 51.13%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for ATRI. What is David A. Batta's approval rating as Atrion's CEO? 1 employees have rated Atrion Chief Executive Officer David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend. What other stocks do shareholders of Atrion own? Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM). What is Atrion's stock symbol? Atrion trades on the NASDAQ under the ticker symbol "ATRI." Who are Atrion's major shareholders? Atrion's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (11.66%), Neuberger Berman Group LLC (10.88%), BlackRock Inc. (6.16%), Dimensional Fund Advisors LP (2.95%), State Street Corp (1.96%) and Boston Trust Walden Corp (1.81%). Insiders that own company stock include Emile A Battat and Jeffery Strickland. View institutional ownership trends. How do I buy shares of Atrion? Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Atrion's stock price today? One share of ATRI stock can currently be purchased for approximately $561.80. How much money does Atrion make? Atrion (NASDAQ:ATRI) has a market capitalization of $988.77 million and generates $183.51 million in revenue each year. The medical instruments supplier earns $35.01 million in net income (profit) each year or $16.82 on an earnings per share basis. How many employees does Atrion have? The company employs 667 workers across the globe. How can I contact Atrion? Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The official website for the company is www.atrioncorp.com. The medical instruments supplier can be reached via phone at (972) 390-9800, via email at ir-info@atrioncorp.com, or via fax at 972-396-7581. This page (NASDAQ:ATRI) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atrion Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.